Friday, June 19, 2026
ASGCT Annual Meeting pharmaceutical event banner
← Back to Events
Tier 1 Global Networking: High GENERAL CONCLUDED

ASGCT Annual Meeting — 2026 — Boston, USA

Annual meeting of the American Society of Gene & Cell Therapy bringing together professionals to advance CGT science, technology, and application with new research and translation approaches.

Boston, USA May 11 – May 15, 2026
2 Presentations
1 Companies
All Events

Presentation data updated Jun 5, 2026, 11:21 AM UTC

Nova Event Impact Score
56 /100
  • Media coverage 20/20
  • Speaker quality 14/20
  • Pipeline relevance 0/20
  • Historical influence 20/20
  • Company participation 2/20

Key Takeaways

Key Themes

generalAmerican Society of Gene & Cell Therapy (ASGCT)Pipeline announcementsPartnership deals

Key Companies

Ascidian Therapeutics

Key Markets

US Americas

Key Opportunities

Partnership dealsLicensing discussionsVendor selection
Best for
Investors & analysts

Full Schedule

2 presentations

POSTER

POSTER

POLARIS program: Phase 1/2 open-label, dose-escalation studies—ENDEAVOR (USA, NCT05419492), WAYFINDER (AUS, NCT06112275), EXPEDITION

Phase I NCT05419492
INVESTOR IMPACT: ★☆☆☆☆ 1/5

OTHER

PRESENTATION

Initial human safety data from RNA exon editing platform in Stargardt disease

Ascidian Therapeutics Stargardt disease